Rotation Medical Initiates Post-Market Clinical Study Of Rotator Cuff Repair System With Bioinductive Implant

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PLYMOUTH, Minn.--(BUSINESS WIRE)--Rotation Medical, a medical device company focused on developing new technologies to treat rotator cuff disease, today announced that it has initiated a multi-center post-market clinical study evaluating the use of the Rotation Medical rotator cuff system in treating supraspinatus rotator cuff tendon tears. The study will be conducted with leading orthopaedic and sports medicine surgeons across the U.S., including Ted Schlegel, MD, from Steadman Hawkins Clinic, Jeffrey Abrams, MD, from Princeton Orthopaedic Associates and Timothy Codd, MD, from Towson Orthopaedic Associates/University of Maryland Medical System, among others.

“We are pleased to conduct this important research with these well respected and accomplished thought leaders,” said Martha Shadan, CEO and President of Rotation Medical. “The information that we gain from this post-market clinical trial will expand the body of evidence documenting the value of the Rotation Medical technology and advance our mission to provide relief for patients by reversing rotator cuff disease progression and restoring long-term shoulder function.”

Help employers find you! Check out all the jobs and post your resume.

Back to news